Johnson & Johnson faces a messy baby powder lawsuit and looming copycat competition for a key medicine, but big shifts in healthcare could still keep its business steadily moving forward. New cancer treatments, more personalized care, and faster drug research may help replace what it loses—if things break the right way.Read more